Scribe Therapeutics, Inc. ($SCTX)
Filing Information
| Accession Number | 0002127908-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 28, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
230,427
Total Value
$39,990.00
P&L
+10479.2% (+$4,190,649.72)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jul 23, 2026 | Purchase | 1,333 | $15.00 | $19,995.00 | 1,333 | Indirect | By Spouse | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 23, 2026 | Purchase | 1,333 | $15.00 | $19,995.00 | 1,333 | Indirect | By Child | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 13, 2026 | Grant/Award | 8,909 | $0.00 | $0.00 | 8,909 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jul 23, 2026 | Grant/Award | 109,426 | $0.00 | $0.00 | 109,426 | Direct | โ | View Details | |
Chief Financial Officer | Performance-based Stock Option (Right to Buy) | Derivative | Jul 23, 2026 | Grant/Award | 109,426 | $0.00 | $0.00 | 109,426 | Direct | โ | View Details |